Enhanced survival and mucosal repair after dextran sodium sulfate-induced colitis in transgenic mice that overexpress growth hormone

Gastroenterology

Volumn 120, Issue 4, 2001, Pages 925-937

  Williams, Kristen L ^a   Fuller, C Randall ^a   Dieleman, Levinus A ^a   DaCosta, Chris M ^a   Haldeman, Kaaren M ^a   Sartor, R Balfour ^a   Lund, P Kay ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXTRAN SULFATE; GROWTH HORMONE; INTERLEUKIN 1BETA; INTESTINAL TREFOIL FACTOR; MESSENGER RNA; SOMATOMEDIN; SOMATOMEDIN C;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL PROLIFERATION; CELL SURVIVAL; COLITIS; COLON MUCOSA; CONTROLLED STUDY; CORRELATION FUNCTION; GENE OVEREXPRESSION; GROWTH HORMONE BLOOD LEVEL; GROWTH HORMONE RELEASE; HISTOPATHOLOGY; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; REMISSION; TRANSGENIC MOUSE;

EID: 0035123651     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/gast.2001.22470     Document Type: Article

References (42)

1. Inflammatory bowel disease: Etiology and pathogenesis
2. Current concepts of the etiology and pathogenesis of ulcerative colitis and Crohn's disease
3. Nutritional issues in inflammatory bowel disease
4. Growth in Crohn's disease
5. Somatomedin-C: Levels in growth-impaired children and adolescents with chronic inflammatory bowel disease
6. Surgical therapy for ulcerative colitis and Crohn's disease
7. A new treatment for patients with short-bowel syndrome. Growth hormone, glutamine, and a modified diet
8. New treatment for patients with short-bowel syndrome: Growth hormone, glutamine and a modified diet
9. Factors predicting a successful outcome after pharmacologic bowel compensation
10. Low-dose recombinant human growth hormone increases body weight and lean body mass in patients with short bowel syndrome
11. Effect of growth hormone, glutamine, and diet on adaptation in short-bowel syndrome: A randomized, controlled study
12. A preliminary study of growth hormone therapy for Crohn's disease
13. Impaired defense of intestinal mucosa in mice lacking intestinal trefoil factor
14. Transforming growth factor β1 null mutation in mice causes excessive inflammatory response and early death
15. Pituitary hormones and the small bowel: Effect of hypophysectomy on intestinal adaptation to small bowel resection in the rat
16. Enhanced growth of small bowel in transgenic mice overexpressing bovine growth hormone
17. Small bowel adaptation with growth hormone and glutamine after massive resection of rat's small bowel
18. Effects of short-term growth hormone therapy in rats undergoing 75% small intestinal resection
19. Human growth hormone induces system B transport in short bowel syndrome
20. Growth hormone and glutamine do not stimulate intestinal adaptation following massive small bowel resection in the rat
21. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice
22. Clinicopathologic study of dextran sulfate sodium experimental murine colitis
23. Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines
24. Fasting prevents experimental murine colitis produced by dextran sulfate sodium and decreases interleukin-1-beta and insulin-like growth factor I messenger ribonucleic acid
25. Involvement of interleukin-1 in the development of ulcerative colitis induced by dextran sulfate sodium in mice
26. Experimental models to study molecular mechanisms underlying intestinal inflammation
27. IGFs and the digestive tract. The insulin-like growth factors system
28. Stimulation of intestinal growth is associated with increased insulin-like growth factor-binding protein 5 mRNA in the jejunal mucosa of insulin-like growth factor-I treated parenterally fed rats
29. Enhanced growth of small bowel in transgenic mice expressing human insulin-like growth factor I
30. Insulin-like growth factor-I and epidermal growth factor interact to regulate growth and gene expression in IEC-6 intestinal epithelial cells
31. One year growth hormone replacement therapy does not alter colonic epithelial cell proliferation in growth hormone deficient adults
32. Expression of insulin-like growth factor I in transgenic mice with elevated levels of growth hormone is correlated with growth
33. Clinical uses of IGF-I and IGF binding protein assays
34. Transforming growth factors β1, β2, and β3 and their receptors are differentially regulated during normal and impaired wound healing
35. Insulin-like growth factor-I and interleukin 1 beta messenger RNA in a rat model of granulomatous enterocolitis and hepatitis
36. Prostaglandins prevent decreased epithelial cell proliferation associated with dextran sodium sulfate injury in mice
37. Growth hormone and insulin-like growth factor I protect intestinal cells from radiation induced apoptosis
38. Inhibition by interleukin-1 beta and tumor necrosis factor-alpha of the insulin-like growth factor I messenger ribonucleic acid response to growth hormone in rat hepatocyte primary culture
39. Proinflammatory cytokines interleukin 1 beta and tumor necrosis factor alpha inhibit growth hormone stimulation of insulin-like growth factor I synthesis and growth hormone receptor mRNA levels in cultured rat liver cells
40. Differential expression and localization of IGF-I and IGF binding proteins in inflamed rat colon
41. IGF-I and procollagen1(I) are co-expressed in a subset of mesenchymal cells in active Crohn's disease
42. Mucosol immunity and inflammation, V. Innate mechanisms of mucosal defense and repair: The best offense is a good defense